Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cobra Biologics Ltd, the International clinical and commercial manufacturer of biologics and pharmaceuticals and Novolytics, a biotechnology company developing anti-infective products, today announce a breakthrough in the development of two ...
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce an agreement to supply a human Fc fusion protein using...
read more
Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Vaccibody AS, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, today announce an...
read more
Wednesday, August 19, 2020
Cobra Biologics CombiGene announced Cobra has successfully produced master cell banks for the three plasmids used as starting material for CombiGene’s gene therapy CG01.
read more
Cobra Biologics has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01, which is being developed for the treatment of drug-resistant focal epilepsy.
read more
Cobra has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01.
read more
Cobra Biologics and the Karolinska Institutet have been awarded €3 million emergency funding by Horizon 2020 for phase I testing of a DNA vaccine against COVID-19.
read more
Monday, November 26, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency.
read more
Wednesday, February 21, 2018
Cobra Biologics and Symbiosis Pharmaceutical Services announced that they have been awarded a 16-month collaborative grant of £1.9m ($2.5m) from Innovate UK.
read more
Cobra Biologics and Symbiosis Pharmaceutical Services announced the successful completion of their collaboration to develop synergistic and world leading capabilities.
read more
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
read more
Cobra Biologics has signed an agreement with AstraZeneca to manufacture the adenovirus vector-based COVID-19 vaccine candidate AZD1222.
read more
Wednesday, October 07, 2020
Cobra Biologics and Scancell Holdings have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine.
read more
Monday, February 06, 2017
Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and other conditions for which many patients find existing treatments to...
read more
Monday, February 11, 2019
Codexis announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical for the supply of a proprietary enzyme to be used in the manufacture of vibegron, an active ingredient in Beova Tablets, a novel, once-daily treatment for ...
read more